ALEXION PHARMACEUTICALS, INC.·4

Mar 5, 8:23 PM ET

SARIN ARADHANA 4

4 · ALEXION PHARMACEUTICALS, INC. · Filed Mar 5, 2019

Insider Transaction Report

Form 4
Period: 2019-02-28
SARIN ARADHANA
Chief Strategy & Business Off
Transactions
  • Award

    Common Stock, par value $.0001 per share

    2019-02-28+8,25030,779 total
Footnotes (1)
  • [F1]Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date.

Documents

1 file
  • 4
    wf-form4_155183538033538.xmlPrimary

    FORM 4